Cuba registers vaccine in Peru for lung cancer

Cuban health authorities in Peru have registered a vaccine for lung cancer that has been tested with positive results in approximately 2,000 patients on the island, as reported by the press in the Caribbean country. CimaVax-EGF vaccine offers the possibility of converting the advanced cancer into a chronic controllable and began marketing in Cuba earlier this year, after having been successfully tested in over 1,000 patients without causing severe adverse effects. “CimaVax-EGF is registered in Cuba and Peru, is underway in Brazil, Argentina, Colombia and other nations and is entitled to patent most of the world,” said the director of the team that developed the treatment, Gisela Gonzalez , in remarks broadcast by the Castro regime’s official newspaper. Read Article